Differential Bio
PrivateLast Round
Pre Seed
Mar 26, 2025
Total Funding Raised
$2.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Differential Bio operates in Healthcare & Life Sciences and is based in Feldkirchen. Its latest recorded funding round was a Pre Seed round in March 2025.
Differential Bio is a biotechnology company that has developed a virtual scale-up platform integrating microbiology, lab automation, and artificial intelligence to optimize and accelerate bioprocesses for the food, cosmetics, and specialty chemicals industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Differential Bio Comparables
Compare Differential Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Novasign GmbH | 84% | |
| Arsenale Bioyards | 78% | |
| DataHow AG | 77% |
For institutional investors. Book with your work email.
Differential Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Differential Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Better Ventures | Pre Seed |
| Climate Capital | Pre Seed |
| Climate Capital | Pre Seed |
| Regenerative Ventures Holdings | Pre Seed |
| Center for Digital Technology and Management | Pre Seed |
| ReGen Ventures | Pre Seed |
| Ananda Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 15, 83% of headcount.
- Mar 27, 2025
Added Carbon13 group, a venture capital firm, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 2, 2026
Differential Bio Inc. develops AI-led fermentation solutions with Cremer Group’s FermBase platform, extending their collaboration to support fermentation companies from early-stage development through industrial scale-up in Germany on Nov 2nd '26.
For institutional investors. Book with your work email.
Differential Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Differential Bio's valuation, stock price, and market status.
Is Differential Bio a public or private company?
Differential Bio is a private company.
What is the current stock price of Differential Bio?
Differential Bio is a private company, so its shares have no public market price. Caplight tracks Differential Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Differential Bio worth (valuation)?
Valuation information for Differential Bio is not publicly available.
Can I buy Differential Bio stock?
Differential Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Differential Bio's last funding round?
Differential Bio's most recent funding round was Pre Seed on March 26, 2025.
Who are the main investors in Differential Bio?
Key investors in Differential Bio include Regenerative Ventures Holdings, ReGen Ventures, Ananda Ventures.
Will Differential Bio IPO soon?
No public IPO plans have been announced for Differential Bio.
How can I track Differential Bio secondary market activity?
Caplight tracks bids, offers, and trades in Differential Bio's shares on secondary markets.